Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood.

Lowe DM, Demaret J, Bangani N, Nakiwala JK, Goliath R, Wilkinson KA, Wilkinson RJ, Martineau AR.

Front Immunol. 2018 Apr 27;9:903. doi: 10.3389/fimmu.2018.00903. eCollection 2018.

2.

Brief Report: HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils.

Bangani N, Nakiwala J, Martineau AR, Wilkinson RJ, Wilkinson KA, Lowe DM.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):263-267.

3.

Effect of Antiretroviral Therapy on HIV-mediated Impairment of the Neutrophil Antimycobacterial Response.

Lowe DM, Bangani N, Goliath R, Kampmann B, Wilkinson KA, Wilkinson RJ, Martineau AR.

Ann Am Thorac Soc. 2015 Nov;12(11):1627-37. doi: 10.1513/AnnalsATS.201507-463OC.

4.

Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.

Kaforou M, Wright VJ, Oni T, French N, Anderson ST, Bangani N, Banwell CM, Brent AJ, Crampin AC, Dockrell HM, Eley B, Heyderman RS, Hibberd ML, Kern F, Langford PR, Ling L, Mendelson M, Ottenhoff TH, Zgambo F, Wilkinson RJ, Coin LJ, Levin M.

PLoS Med. 2013 Oct;10(10):e1001538. doi: 10.1371/journal.pmed.1001538. Epub 2013 Oct 22.

5.

A novel assay of antimycobacterial activity and phagocytosis by human neutrophils.

Lowe DM, Bangani N, Mehta MR, Lang DM, Rossi AG, Wilkinson KA, Wilkinson RJ, Martineau AR.

Tuberculosis (Edinb). 2013 Mar;93(2):167-78. doi: 10.1016/j.tube.2012.11.014. Epub 2013 Jan 17.

6.

A recent HIV diagnosis is associated with non-completion of Isoniazid Preventive Therapy in an HIV-infected cohort in Cape Town.

Oni T, Tsekela R, Kwaza B, Manjezi L, Bangani N, Wilkinson KA, Coetzee D, Wilkinson RJ.

PLoS One. 2012;7(12):e52489. doi: 10.1371/journal.pone.0052489. Epub 2012 Dec 20.

7.

Smoking, BCG and employment and the risk of tuberculosis infection in HIV-infected persons in South Africa.

Oni T, Gideon HP, Bangani N, Tsekela R, Seldon R, Wood K, Wilkinson KA, Goliath RT, Ottenhoff TH, Wilkinson RJ.

PLoS One. 2012;7(10):e47072. doi: 10.1371/journal.pone.0047072. Epub 2012 Oct 9.

8.

Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment.

Oni T, Gideon HP, Bangani N, Tsekela R, Seldon R, Wood K, Wilkinson KA, Goliath RT, Ottenhoff TH, Wilkinson RJ.

Clin Vaccine Immunol. 2012 Aug;19(8):1243-7. doi: 10.1128/CVI.00166-12. Epub 2012 Jun 20.

9.

Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.

Martineau AR, Nhamoyebonde S, Oni T, Rangaka MX, Marais S, Bangani N, Tsekela R, Bashe L, de Azevedo V, Caldwell J, Venton TR, Timms PM, Wilkinson KA, Wilkinson RJ.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19013-7. doi: 10.1073/pnas.1111825108. Epub 2011 Oct 24.

10.

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.

Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, Wood K, Wilkinson KA, Ottenhoff TH, Wilkinson RJ.

Thorax. 2011 Aug;66(8):669-73. doi: 10.1136/thx.2011.160168. Epub 2011 May 31.

11.

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS.

Clin Infect Dis. 2009 Apr 1;48(7):856-62. doi: 10.1086/597262.

12.

Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa.

Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobongwana M, Dockrell HM, Wilkinson RJ, Wood R.

BMC Infect Dis. 2007 Aug 28;7:99.

Supplemental Content

Loading ...
Support Center